Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cornea ; 19(4): 464-7, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10928758

RESUMO

PURPOSE: To assess the efficacy of three drugs in different concentrations against different strains of Acanthamoeba using the reculture technique. METHODS: Cysts and trophozoites were immersed in five separate solutions. The solutions administered included 0.1% and 0.02% polyhexamethylene biguanide (PHMB), 0.1% and 0.02% chlorhexidine, and propamidine isethionate (Brolene). Readings took place after 1, 5, and 24 hours. The cysts and trophozoites were then recultured for an additional period of 48 hours. An effective drug was defined as a medication that inhibited any growth of trophozoites using the reculture technique. RESULTS: Chlorhexidine at concentrations of 0.1% and 0.02% was the only effective drug against all five strains of Acanthamoeba examined, and no trophozoites were detected on plates immersed with this agent. Only 0.1% chlorhexidine was effective in destroying all cysts in the five strains examined. CONCLUSION: We found that 0.02% chlorhexidine was efficient in irradicating all trophozoites and 0.1% chlorhexidine was effective in eradicating all cysts in the samples we examined. Therefore, it may be possible that 0.02% chlorhexidine is a good initial treatment in amoebic keratitis. Sensitivity testing, then, may be performed using the reculture technique and specification of therapy can be made accordingly.


Assuntos
Ceratite por Acanthamoeba/tratamento farmacológico , Acanthamoeba/efeitos dos fármacos , Benzamidinas/administração & dosagem , Biguanidas/administração & dosagem , Clorexidina/administração & dosagem , Córnea/parasitologia , Testes de Sensibilidade Parasitária/métodos , Acanthamoeba/crescimento & desenvolvimento , Ceratite por Acanthamoeba/parasitologia , Adolescente , Adulto , Animais , Antiprotozoários/administração & dosagem , Criança , Pré-Escolar , Meios de Cultura/farmacologia , Desinfetantes/administração & dosagem , Feminino , Humanos , Masculino , Soluções Oftálmicas
2.
Graefes Arch Clin Exp Ophthalmol ; 235(4): 200-3, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9143886

RESUMO

OBJECTIVES: (1) To prospectively evaluate the incidence of increased intraocular pressure (IOP) in patients suffering from chronic uveitis. (2) To identify the main factors responsible for an increase in the IOP among these patients. METHODS: Two hundred and one patients suffering from chronic uveitis were included. Enrolled patients had an initial IOP of 8-18 mmHg. The patients were treated and clinically monitored during a period of 4 years. The IOP was measured at each visit and its changes followed prospectively. All patients were followed up for at least 12 months after enrollment. RESULTS: Twenty-four (12%) of the 201 patients had IOP higher than 24 mmHg at two or more consecutive visits. Of these 24 patients, 19 suffered from bilateral uveitis and 5 had unilateral disease. Four of the 19 patients with bilateral uveitis developed a constant IOP higher than 24 mmHg in both eyes, while in 15 patients an IOP higher than 24 mmHg persisted only in one eye. A close association between the increased IOP and the use of corticosteroids was found in 18 of the 24 cases (75%). This association was ascertained in 16 of these patients by the decrease in IOP levels on discontinuation of the corticosteroid regimen and the renewed increase IOP was due to pupillary block in three cases (12.5%), to iris and angle neovascularization in two (8.3%), and to the inflammatory process per se in one case only (4.2%). CONCLUSIONS: This study demonstrates that a persistent elevation of the IOP in patients suffering from chronic uveitis is, in the majority of cases, associated with the use of corticosteroids.


Assuntos
Dexametasona/efeitos adversos , Glucocorticoides/efeitos adversos , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/induzido quimicamente , Uveíte/tratamento farmacológico , Adolescente , Antagonistas Adrenérgicos beta/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Feminino , Fluormetolona/administração & dosagem , Fluormetolona/efeitos adversos , Fluormetolona/uso terapêutico , Seguimentos , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Hipertensão Ocular/terapia , Soluções Oftálmicas , Prednisolona/administração & dosagem , Prednisolona/efeitos adversos , Prednisolona/uso terapêutico , Estudos Prospectivos , Uveíte/etiologia
3.
Artigo em Inglês | MEDLINE | ID: mdl-2370832

RESUMO

A three-month old, premature female infant is presented with severe bilateral occult ocular damage comprised of cataracts, lenses dislocation, retinal hemorrhages and total funnel-shaped retinal detachment without external signs such as bruises. This severe eye trauma is the result of child abuse. We would like to alert pediatricians as well as ophthalmologists that any ocular injury should raise the possible diagnosis of battered child syndrome even in the absence of other supportive evidence of external trauma.


Assuntos
Síndrome da Criança Espancada/diagnóstico , Maus-Tratos Infantis/diagnóstico , Traumatismos Oculares/etiologia , Síndrome da Criança Espancada/complicações , Catarata/etiologia , Feminino , Fundo de Olho , Humanos , Lactente , Subluxação do Cristalino/etiologia , Descolamento Retiniano/etiologia , Hemorragia Retiniana/etiologia
4.
Invest Ophthalmol Vis Sci ; 29(2): 194-9, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3338879

RESUMO

The effect of sodium hyaluronate (NaHa) 1% and 0.1% was studied on 14-day chick embryo corneal epithelium by scanning electron microscopy. It was found that NaHa 1% or 0.1% had no toxic effects on the chick corneal epithelium and the normal architecture of the cells and the morphology of the microvilli was well preserved. A combination of NaHa 0.1% and benzalkonium chloride (BAK) 0.01% reduced the toxic effect of BAK on the surface corneal epithelium. NaHa 0.1% provided a better protection of the corneal epithelium against dryness than hydroxyethylcellulose (HEC) 0.1% or phosphate buffer saline (PBS).


Assuntos
Endotélio Corneano/efeitos dos fármacos , Ácido Hialurônico/farmacologia , Animais , Compostos de Benzalcônio/farmacologia , Celulose/análogos & derivados , Celulose/farmacologia , Embrião de Galinha , Endotélio Corneano/citologia , Endotélio Corneano/ultraestrutura , Microscopia Eletrônica de Varredura , Fosfatos/farmacologia , Cloreto de Sódio/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA